Option chain shows key data for CONX's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for CONX.

CONX (OTC:CNXXW) Stock, Option Chain

CONX Corp

News

ACIW

ACI Worldwide To Protect Zimbabwe's Payments Landscape Through Partnership With Zimswitch

Third Quarter 2024 Operational Highlights
<ul>
<li>Total number of paying clients1 increased 33.1% year-over-year to 2,196,647 as of September 30, 2024.</li>
<li>Total number of registered clients2 increased 22.8% year-over-year to 4,284,786 as of September 30, 2024.</li>
<li>Total number of users3 increased 14.4% year-over-year to 24.1 million as of September 30, 2024.</li>
<li>Total client assets increased 48.1% year-over-year to HK$693.4 billion as of September 30, 2024.</li>
<li>Daily average client assets were HK$593.2 billion in the third quarter of 2024, an increase of 23.4% from the same period in 2023.</li>
<li>Total trading volume in the third quarter of 2024 increased by 74.7% year-over-year to HK$1.90 trillion, in which trading volume for U.S. stocks was HK$1.53 trillion, and trading volume for Hong Kong stocks was HK$347.7 billion.</li>
<li>Daily average revenue trades (DARTs)4 in the third quarter of 2024 increased 68.0% year-over-year to 698,811.</li>
<li>Margin financing and securities lending balance increased 25.5% year-over-year to HK$40.6 billion as of September 30, 2024.</li>
</ul>

Earnings

FUTU

FUTU's Q3 Total Number Of Paying Clients Increased 33.1% YoY; Total Number Of Users +14.4%YoY; Total Client Assets +48.1% YoY; Total Trading Volume +74.7% YoY

Lowe&#8217;s Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) will release earnings results for its third quarter, before the <a href="https://www.benzinga.com/quote/LOW/earnings">opening bell on Tuesday, Nov. 19.</a>
Analysts expect the Mooresville, North Carolina-based company to report quarterly earnings at $2.81 per share, down from $3.06 per share in the year-ago period. Lowe&#8217;s projects to report quarterly revenue of $19.91 billion, compared to $20.47 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Aug. 20, the company reported adjusted earnings per share of $4.10, beating the analyst consensus of $3.99. Quarterly revenues totaled $23.586 billion, missing the street view of $24.013 billion.
Lowe&#8217;s shares gained 0.9% to close at $271.77 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/LOW/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Telsey Advisory Group analyst Joseph Feldman upgraded the stock from Market Perform to Outperform and raised the price target from $275 to $305 on Nov. 8. This analyst has an accuracy rate of 69%.</li>
<li>Truist Securities analyst Scot Ciccarelli maintained a Buy rating and increased the price target from $306 to $307 on Nov. 7. This analyst has an accuracy rate of 75%.</li>
<li>Wells Fargo analyst Zachary Fadem maintained an Overweight rating and raised the price target from $280 to $295 on Nov. 6. This analyst has an accuracy rate of 87%.</li>
<li>TD Cowen analyst Max Rakhlenko maintained a Hold rating and boosted the price target from $270 to $290 on Oct. 28. This analyst has an accuracy rate of 61%.</li>
<li>Loop Capital analyst Laura Champine upgraded the stock from Hold to Buy and increased the price target from $250 to $300 on Oct. 9. This analyst has an accuracy rate of 64%.</li>
</ul>
Considering buying LOW stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="559" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19020841/image-185-1024x559.png" alt="" class="wp-image-654276" style="width:626px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19020841/image-185-1024x559.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19020841/image-185-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19020841/image-185-768x419.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19020841/image-185.png 1222w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42035732/jim-cramer-super-group-basic-materials-stock-is-very-hard-to-own-here">Jim Cramer: Super Group Finally &#8216;Broke Out,&#8217; This Basic Materials Stock Is &#8216;Very Hard To Own Here&#8217;</a></li>
</ul>

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

Lowe's Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Futu Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>) reported quarterly earnings of HK$9.42 per share which missed the analyst consensus estimate of HK$9.85 by 4.37 percent. This is a 19.85 percent increase over earnings of HK$7.86 per share from the same period last year. The company reported quarterly sales of HK$3.436 billion which beat the analyst consensus estimate of HK$3.209 billion by 7.07 percent. This is a 29.66 percent increase over sales of HK$2.650 billion the same period last year.

Earnings Beats

Earnings Misses

Futu Holdings Q3 2024 Adj. EPS HK$9.42 Misses HK$9.85 Estimate, Sales HK$3.436B Beat HK$3.209B Estimate

Rapper Heather Morgan, known as the &#8216;Crocodile of Wall Street&#8217;, is set to serve 18 months in prison for conspiring with her hacker husband to launder billions of dollars of stolen Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).
What Happened: Morgan, 34, was sentenced on Monday in a federal court in Washington for her role in the sensational cyberattack on cryptocurrency exchange&nbsp;Bitfinex in 2016, according to a <a href="https://www.bloomberg.com/news/articles/2024-11-18/hacker-s-wife-razzlekhan-gets-18-months-for-money-laundering">report </a>by Bloomberg. Her spouse and hack mastermind, Ilya Lichtenstein, has already been awarded a <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42011697/bitcoin-hacker-sentenced-to-5-years-for-laundering-billions-in-crypto-theft">five-year sentence</a>. 
See Also: <a href="https://www.benzinga.com/trading-ideas/movers/24/11/42053981/trump-sec-pick-speculation-sends-this-altcoin-soaring-past-bitcoin-and-ethereum-in-daily-gains">Trump SEC Pick Speculation Sends This Altcoin Soaring Past Bitcoin And Ethereum In Daily Gains</a>
Morgan became a well-known figure in Twitter's (now X) high-finance community for posting obscure rap videos under the moniker &#8220;The Crocodile of Wall Street.&#8221;
Why It Matters: Morgan and Lichtenstein were <a href="https://www.benzinga.com/markets/cryptocurrency/23/01/30468047/from-wall-street-to-tech-company-hire-the-story-of-the-crocodile-and-the-120-000-bitcoin-h">charged</a> by the Justice Department in February 2022 in what has been described by authorities as one of the most sophisticated money-laundering operations ever encountered in the cryptocurrency space.
The hack targeted Hong Kong-based exchange Bitfinex in 2016, compromising 36% of the company&#8217;s assets. About 119,754 BTCs were stolen in the attack, worth about $71 million at that time and over $11 billion today. By 2022, the couple had successfully laundered around 21% of the stolen funds, worth $14 million at 2016 prices and exceeding $1 billion in 2022.
Authorities recovered over 96% of the stolen Bitcoin, valued at over $6 billion, thanks in part to Lichtenstein&#8217;s cooperation following his arrest in 2022.
Last year, the couple <a href="https://www.benzinga.com/markets/cryptocurrency/23/08/33566259/razzlekhan-and-husband-plead-guilty-in-multibillion-dollar-bitcoin-laundering-case">pleaded guilty</a> to charges. Morgan, who was not part of the original hack, was enlisted by Lichtenstein to launder the stolen digital currency.
Price Action: At the time of writing, Bitcoin was trading at $91,943.90, up 0.84% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Photo Courtesy: Shutterstock.com
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42052797/trump-and-coinbase-ceo-brian-armstrong-reportedly-in-talks-over-cabinet-appointments">Trump And Coinbase CEO Brian Armstrong Reportedly In Talks Over Cabinet Appointments</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitfinex Bitcoin Laundering Case Lands 'Crocodile Of Wall Street' In Jail

BW LPG is pleased to announce that its 52% owned subsidiary BW LPG India has decided to sell its 2007-built vessel BW Cedar as part of a planned fleet renewal. On a 100% basis, the sale is priced at approximately US$65 million and is expected to generate a net book gain of around US$33 million and about US$51 million in net cash after repayment of its existing bank loan. The vessel will be delivered to the new owners in Q1 2025.
In addition, BW LPG has declared a purchase option for BW Kizoku, a 2019 Japan-built VLGC. BW Kizoku is currently on time charter with BW LPG with a purchase option, which BW LPG exercised for a consideration of US$69.8 million. The vessel is expected to be delivered in January 2025 and will continue to trade in the conventional BW LPG fleet.

BWLP

BW LPG Sells 2007-Built BW Cedar For $65M, Acquires Modern 2019-Built BW Kizoku For $69.8M

<ul>
<li>Approximately €70 Million in Upfront and Near-term Payments to Cytokinetics</li>
<li>Up to €490 Million in Commercial Milestone Payments, with</li>
<li>Tiered Royalties on Future Sales</li>
</ul>

BAYRY

CYTK

Cytokinetics And Bayer Partner For Exclusive Development And Commercialization Of Aficamten In Japan

<ul>
<li>EPIC Advanced Packaging marks an expansion of Applied's global innovation platform</li>
<li>Company convenes top semiconductor R&amp;D leaders to advance high-performance, low-power AI chip packaging technologies</li>
</ul>

AMAT

Applied Materials Expands Global Innovation Platform With Advanced Packaging Collaboration For AI Era

Proceeds to be used primarily to acquire bitcoin and repurchase existing convertible notes due 2026

MARA

Reported Earlier, MARA Holdings Prices $850M Oversubscribed And Upsized Zero-Coupon Convertible Notes Offering Due 2030

Hyperlux advanced imaging capabilities capture most accurate visual data to ensure error-free interpretation of driving environments and enhance car safety&nbsp;
NEWS HIGHLIGHTS
<ul>
<li>onsemi will be the primary supplier of image sensors for Subaru's next-generation EyeSight stereo-camera front sensing system</li>
<li>Hyperlux image sensors feature whole pixel design and High Dynamic Range to significantly improve image clarity and accuracy</li>
<li>Equipped with functional safety features, Hyperlux sensors ensure greater level of safety and reliability of the system</li>
<li>Selection follows longstanding collaboration between companies to improve vehicle safety by tailoring sensors to multiple generations of Subaru's stereo-camera front sensing system</li>
</ul>

Reported Earlier, Subaru Selects onsemi Hyperlux Sensors To Enhance AI-Integrated EyeSight Driver Assistance System

Monthly tobevibart and elebsiran combination achieves rapid 100% virologic suppression at Week 24, sustained through Week 60 –
– Undetectable HDV RNA in 41% of participants at Week 24, increasing to 64% by Week 36 and up to 80% by Week 60 across cohorts –
– Combination well-tolerated: no treatment-related severe AEs, treatment-related discontinuations or ALT flares –
– Following a recent FDA meeting, Phase 3 ECLIPSE registrational program to begin in the first half of 2025 –

Reported Earlier, Vir Biotechnology Announces Phase 2 Data And Phase 3 Launch For Chronic Hepatitis Delta Treatment

SYRE

Reported Earlier, Spyre Therapeutics Prices $200M Public Offering Of 7.275M Common Shares At $27.50/Share

The gross proceeds to the Company from the registered direct offering and concurrent private placement are estimated to be approximately $6.9 million before deducting the placement agent's fees and other offering expenses payable by the Company. The offering is expected to close on or about November 20, 2024, subject to the satisfaction of customary closing conditions.

HCWB

Reported Earlier, HCW Biologics Announces $6.9M Direct Offering And Private Placement Priced Above Market

Select intends to use the net proceeds of the Offering, together with the proceeds from the proposed new incremental term loan and cash on hand, to repay in full the term loans currently outstanding under Select's existing senior secured credit agreement, to redeem all of Select's outstanding 6.250% senior notes due 2026 and to pay fees and expenses related to the foregoing.&nbsp;

Reported Earlier, Select Medical Announces Pricing of $550M 6.250% Senior Notes Due 2032

The fundamentals of our business are strong. Our AirSCWO technology is performing well across biosolid/sludge and liquid waste streams. Our DaaS business is taking shape representing near-term recurring revenue, with our first operating site being actively negotiated to destroy non-hazardous waste, and our conversations are advancing with TSDF operators for onsite non-hazardous and hazardous waste destruction. Our approach to opening markets is bearing fruit with opportunities across AFFF, GAC, IX, and other organic waste streams. Our current backlog/pipeline exceeds $1.8B and we believe this will grow further.

SCWO

Reported Earlier, 374Water Highlights Commercial Milestones, $1.8B Pipeline, And Growing Opportunities In Waste Management

Telix's development program will initially focus on the treatment of bladder cancer, rounding out its urology franchise, which includes late-stage therapeutic programs for kidney and prostate cancers.
FAP is a pan-cancer marker expressed in the tumor microenvironment of epithelial cancers and on the surface of some specific cancer types, including sarcomas and mesotheliomas.

Reported Earlier, Telix Expands Theranostic Pipeline With FAP-Targeting Radiopharmaceuticals For Pan-Cancer Treatment

The Company stated that while its financial position remains sound, the Board of Directors determined that the reduction in the dividend was prudent given the Company's recent operating performance. As previously disclosed, the Company has been implementing multiple initiatives to improve performance that have led to year-over-year performance improvement. These include price adjustments with our customers and cost reduction projects, including the previously disclosed consolidation of the&nbsp;Albia, Iowa operation into the Tyrone, Pennsylvania operation.

Reported Earlier, Chicago Rivet & Machine Reduces Quarterly Dividend To $0.03 Per Share From $0.10 Per Share, Payable December 20, 2024

ZENV

Reported Earlier, Zenvia Q3 Sales R$284.400M Beat R$249.810M Estimate; Net Income R$52.62M Up From Net loss R$11.94M

ZEPP

Reported Earlier, Zepp Health Q3 EPS $(0.78) Down From $0.12 YoY, Sales $42.50M Down From $82.53M YoY

<ul>
<li>IPH6501 is a first-in-class tetra-specific NK cell engager armed with a variant of IL-2, targeting CD20 and developed for B-NHL</li>
<li>IPH6501 boosts NK cell proliferation and cytotoxicity, showing activity in vitro against a range of B-NHL cell lines, in vivo in various preclinical models and ex vivo in samples from R/R B-NHL patients</li>
<li>In vivo studies further validated that IPH6501 augments the ability of peripheral NK cells to migrate and infiltrate tumors</li>
<li>Results support clinical development of IPH6501 in R/R B-NHL</li>
</ul>

Comments

CONX

CONX (CNXXW) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga